CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
14 research outputs found
Evaluation of Hepatic Impairment Dosing Recommendations in FDA-Approved Product Labels
Author
Amgen Inc
Celgene Corporation
+20 more
Delcò
Eisai Inc
Forest Pharmaceuticals Inc
GlaxoSmithKline
Jellinek
Lundbeck Inc
Novartis Pharma Stein AG
Novartis Pharmaceuticals Corporation
Otsuka Pharmaceutical Co. Ltd
Pfizer Inc
Pfizer Inc
Sanofi-Aventis
Sanofi-Aventis
Sunovion Pharmaceuticals Inc
Verbeeck
Vertex Pharmaceuticals Incorporated
ViiV Healthcare
Warner Chilcott (US) LLC
Xu
Younossi
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Novel pharmacological treatments for generalized anxiety disorder: Pediatric considerations
Author
Acadia Pharmaceuticals Inc
Bond A.
+7 more
Dobson E. T.
Helton D. R.
ITF Pharma Inc
Pilc A.
Sanofi‐Aventis U.S. LLC.
Sunovion Pharmaceuticals Inc
Tsuang M. T.
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019
Author
AbVie Inc
Agouron Pharmaceuticals Inc
+14 more
Briggs G
Chan KS
Clerici M
Concordia Pharmaceuticals Inc
Elli Lilly and Company
Genentech Inc
Koren G
Merck & Co. Inc
Merck & Co. Inc
Romark Pharmaceuticals
Sanofi‐Aventis USLLC
The COVID‐19 Investigation Team
Xu X
Zhonghua J
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
A Pharmacology Perspective on Simultaneous Tuberculosis and Hepatitis C Treatment
Author
AbbVie
AbbVie Inc
+23 more
Bayer Healthcare Pharmaceuticals
Bristol-Myers Squibb
Chien JY
Feng PC
Gilead Sciences Inc
Gilead Sciences Inc
Gilead Sciences Inc
Gumbo T
Janssen Pharmaceuticals Inc
Janssen Therapeutics
Janssen Therapeutics
Keung A
Merck Sharp & Dohme Corp
Nariman S
Reith K
Sanofi-Aventis
Stada Pharmaceuticals Inc
WHO
WHO
WHO
WHO
Wyeth Pharmaceuticals Inc
Zhaoxu L
Publication venue
'American Society for Microbiology'
Publication date
Field of study
No full text
Crossref
Applications of population pharmacokinetics in current drug labelling
Author
Aarons L
Abbot Laboratories
+28 more
Abbott Laboratories
Aventis
Aventis Pharmaceuticals
Cephalon
Duan J
FDA
FDA (1999) Guidance for Industry: Population Pharmacokinetics
Genentech
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline
GlaxoSmithKline
Grasela TH
Grasela TH
Grasela TH
Karlsson MO
Kelman AW
Kristjansson F
Ludden TM
Novartis
Ochs HR
Panetta JC
Pfizer Inc
Roche
Rowinsky EK
Thomson Corp
Valeant Pharmaceuticals
Wedel M
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
Syndrome de Lyell au léflunomide (Arava®)
Author
Aventis Pharmaceuticals Inc. Arava Prescribing Information as of March
Bandyopadhyay
+22 more
Breedveld
Bégaud
Canonne-Courivaud
Carulli
Chalbi Belkahia
Chan
Cohen
Fischer
Issam Salouage
Li
MacDonald
Martin
Mladenovic
Mohamed Hédi Loueslati
Mohty
Riadh Daghfous
Samia Srairi
Sarrah Kastalli
Sihem El Aïdli
Smolen
Soliotis
Teraki
Publication venue
'EDP Sciences'
Publication date
Field of study
No full text
Crossref
Drug interactions between antiretrovirals and drugs used to treat benign prostatic hyperplasia/lower urinary tract symptoms
Author
Abbott Laboratories Limited
AbbVie Corporation
+46 more
AbbVie Corporation
Alice Tseng
Bayer Inc
Boehringer Ingelheim (Canada) Ltd
Boehringer Ingelheim (Canada) Ltd
Boehringer Ingelheim (Canada) Ltd
Boehringer Ingelheim Pharmaceuticals Inc
Bristol-Myers Squibb Canada
Bristol-Myers Squibb Canada
Canadian Pharmacists Association (CPhA)
Clark RV
Crauwels HM
Crauwels HM
Denise Kreutzwiser
Eli Lilly Canada
Eli Lilly Canada Inc
Gilead Sciences Canada Inc
Gilead Sciences Canada Inc
GlaxoSmithKline Inc
Hesse LM
Hoffmann-La Roche Limited
Huskey SW
Ishii Y
Janssen Inc
Janssen Inc
Janssen Inc
Joint United Nations Programme on HIV/AIDS (UNAIDS)
Kakuda TN
Kapoor A
Lee L
McConnell JD
Merck Canada Inc
Merck Canada Inc
Merck Canada Inc
Pfizer Canada Inc
Pfizer Canada Inc
Pfizer Canada Inc
Roehrborn C
Roehrborn CG
Sanofi-Aventis Canada Inc
Schöller-Gyüre M
Taguchi K
ViiV Healthcare ULC
ViiV Healthcare ULC
Vourvahis M
Watson Laboratories Inc
Publication venue
'Informa UK Limited'
Publication date
Field of study
No full text
Crossref
Review article: the role of serotonergic agents in the treatment of patients with primary chronic constipation
Author
Aventis Pharmaceuticals Inc
Berrada D
+41 more
Bjornsson ES
Bjornsson ES
Brandt LJ
Camilleri M
Chey WD
Crowell MD
Crowell MD
Devor DC
Feng F
Gershon MD
GlaxoSmithKline
GlaxoSmithKline
Harris ML
Herz MJ
Ji S-W
Jiao HM
Johanson JF
Locke GR
Mine Y
Mueller-Lissner S
Muller-Lissner SA
Muller-Lissner SA
Novartis Pharmaceuticals Corporation
Nyhlin H
O'Keefe EA
Potet F
Reilly MC
Roche Laboratories Inc
Sabate J
Schiller LR
Singh G
Singh G
Stephenson JJ
Stoner MC
Suh D-C
Thompson WG
Thompson WG
Veldhuyzen Van Zanten SJ
Verheyen KVM
Wood JD
Yoshida N
Publication venue
'Wiley'
Publication date
Field of study
No full text
Crossref
The one-two punch: Combination treatment in chronic myeloid leukemia
Author
Arroyo
Astellas Pharma Inc
+101 more
Bewry
Bristol-Myers-Squibb
Bristol-Myers-Squibb
Brown
Brown
Burgess
Carayol
Carlesso
Chen
Chu
Copland
Corbin
Cortes
de Haan
Deeg
Deininger
Deininger
Den
Dierks
Eghtedar
Eli Lilly and Company
Eli Lilly and Company
Essers
Foster
Garcia-Manero
Graham
Gregory
Gupta
Hege
Hehlmann
Heidel
Heisterkamp
Hochhaus
Huff
Isis Pharmaceuticals
Jakafi
Jamieson
Janes
Javier Pinilla-Ibarz
Kantarjian
Kantarjian
Kendra L. Sweet
Komrokji
Konig
Konig
Levine
Levis
Lie
Lori A. Hazlehurst
Mahon
Mahon
Mar
Minucci
Nair
Nair
Nam
Nelson
Neviani
Novartis Pharmaceuticals
Novartis Pharmaceuticals
Nowell
Otsuka Pharmaceutical
O’Brien
Palandri
Perrotti
Pfizer Inc
Pfizer Inc
Preudhomme
Ravandi-Kashani
Rawlings
Ross
Rousselot
Rousselot
Rowley
Saglio
Samanta
Sanofi-Aventis
Santos
Silverman
Simonsson
Sterling
Switzer
Talpaz
Teachey
Tefferi
Trowbridge
Turhan
Verstovsek
Verstovsek
Verstovsek
Verstovsek
Verstovsek
Verstovsek
Verstovsek
Vose
Warsch
Yee
Younes
Younes
Zhang
Zhao
Publication venue
'Elsevier BV'
Publication date
Field of study
No full text
Crossref
5-hydroxytryptamine type-3 receptor antagonists for chemotherapy-induced and radiotherapy-induced nausea and emesis
Author
Aapro
Aapro
+87 more
Andrews
Andrews
Audhuy
Aventis Pharmaceuticals Inc.
Beck
Beck
Bentley
Bleiberg
Blower
Blower
Blower
Bonhaus
Bosnjak
Bubalo
Carmichael
Coates
Cooper
Davis
de Boer-Dennert
de Wit
de Wit
Dempsey
Doherty
Eiselé
Eisenberg
Eisenberg
Elliott
Gandara
Gebauer
GlaxoSmithKline
Gralla
Gralla
Griffin
Grote
Grunberg
Grunberg
Grunberg
Hacking
Hargreaves
Hesketh
Hesketh
Hu
Ingelman-Sundberg
Jann
Jantunen
Jordan
Kaiser
Kamanabrou
Koeller
Koffman
Kris
Laszlo
Lindley
Mantovani
Martin
Martin
Marty
MGI Pharma Inc.
Minami
Molassiotis
Morrow
Navari
Navari
Needles
Newberry
Novartis Pharmaceuticals Australia Pty Ltd.
Parker
Riviere
Roche Laboratories
Ruff
Sanchez
Schnell
Seynaeve
Sigsgaard
Smith
Soukop
Soukop
Steele
Sweetland
Terrey
Tsavaris
Upward
van Belle
van Hooft
Wong
Wymenga
Xu
Publication venue
'Wiley'
Publication date
01/01/2005
Field of study
No full text
Crossref
1
2